STUDENTS’ RESEARCH ACTIVITY AS A CONTRIBUTION TO MODERN UNIVERSITY

Por Boris Manov, Valentina Milenkova
Publicado em 2018-08-01

MEDIA EDUCATION POLICY IN BULGARIA

Por PEICHEVA,Dobrinka, MILENKOVA,Valentina
Publicado em 2016-03-01

Old syndrome–new approach: Mauriac syndrome treated with continuous insulin delivery

Por Mirjana Kocova, Liljana Milenkova
Publicado em 2018-06-01

Old syndrome–new approach: Mauriac syndrome treated with continuous insulin delivery

Por Kocova, Mirjana, Milenkova, Liljana
Publicado no SAGE Open Med Case Rep (2018)

Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination therapy trials

Por Alecu, Iulian, Milenkova, Tsveta, Turner, Simon R
Publicado no Drug Des Devel Ther (2018)

First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study

Por Douillard, J-Y, Ostoros, G, Cobo, M, Ciuleanu, T, McCormack, R, Webster, A, Milenkova, T
Publicado em 2014

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status

Por Douillard, Jean-Yves, Ostoros, Gyula, Cobo, Manuel, Ciuleanu, Tudor, Cole, Rebecca, McWalter, Gael, Walker, Jill, Dearden, Simon, Webster, Alan, Milenkova, Tsveta, McCormack, Rose
Publicado no J Thorac Oncol (2014)

DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study

Por Mross, Klaus, Fasol, Ulrike, Frost, Annette, Benkelmann, Robin, Kuhlmann, Jan, Büchert, Martin, Unger, Clemens, Blum, Hubert, Hennig, Jürgen, Milenkova, Tsveta P, Tessier, Jean, Krebs, Annetta D, Ryan, Anderson J, Fischer, Richard
Publicado em 2009